SCHEMBL2530401

SCHEMBL2530401

CC(=O)c1cc2cc(c1)C(=O)N[C@H]([C@H](O)CNC1(c3cccc(C(C)C)c3)CC1)Cc1cccc(c1)OCCCCO2

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.75
CTSD P07339 7/20 0.75
CTSE P14091 4/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533507 0.94 BACE1 (0.69) BACE1CTSDCTSE
SCHEMBL3969661 0.94 BACE1 (0.74) BACE1CTSDCTSE
SCHEMBL2530167 0.92 BACE1 (0.80) BACE1CTSDCTSE
SCHEMBL2526933 0.90 BACE1 (0.66) BACE1CTSDCTSE
SCHEMBL3969665 0.90 BACE1 (0.76) BACE1CTSDCTSE
SCHEMBL2533578 0.89 BACE1 (0.71) BACE1CTSDCTSE
SCHEMBL2532537 0.86 BACE1 (0.83) BACE1CTSDCTSE
SCHEMBL3969588 0.86 BACE1 (0.79) BACE1CTSDCTSE
SCHEMBL2530955 0.85 BACE1 (1.00) BACE1CTSDCTSE
SCHEMBL2531564 0.85 BACE1 (1.00) BACE1CTSDCTSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039455-B2 Macrocyclic compounds useful as BACE inhibitors NOVARTIS AG (CH) 2011-10-18 US claimed